SEC Company Response from Aptose Biosciences Inc. (CIK 0000882361) (APTOF) — Apr 23, 2019

Aptose Biosciences Inc. (CIK 0000882361)
Date: April 23, 2019 · CIK: 0000882361 · Accession: 0001171843-19-002558

View on Edgar

AI Filing Summary & Sentiment

File numbers found in text: 333-230218

Date

April 23, 2019

Author

Not clearly detected

Form

CORRESP

Company

Aptose Biosciences Inc. (CIK 0000882361)

Letter

Re: Aptose Biosciences Inc.

April 23, 2019

Via EDGAR

Securities and Exchange Commission

100 F Street N.E.

Washington, D.C. 20549-7010

USA

Registration Statement on Form S-3

Filed March 12, 2019, as amended

File No. 333-230218

Pursuant to Rule 461(a) under the Securities Act of 1933, as amended (the “Securities Act”), Aptose Biosciences Inc. (the “Company”) hereby respectfully requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement (the “Registration Statement”) to April 25, 2019 at 4:00 p.m. (Eastern) or as soon thereafter as is practicable.

The Company also requests the Commission confirm the effective date and time of the Registration Statement in writing.

APTOSE BIOSCIENCES INC.

/s/ Gregory K. Chow

Name: Gregory K. Chow

Title: Senior Vice President & Chief

Financial Officer

Show Raw Text

CORRESP
1
filename1.htm

April 23, 2019

    Via EDGAR

        Securities and Exchange Commission

        100 F Street N.E.

        Washington, D.C. 20549-7010

        USA

Re:  Aptose Biosciences Inc.

Registration Statement on Form S-3

Filed March 12, 2019, as amended

File No. 333-230218

Pursuant to Rule 461(a) under the Securities Act of 1933, as amended
(the “Securities Act”), Aptose Biosciences Inc. (the “Company”) hereby respectfully requests that the Securities
and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement
(the “Registration Statement”) to April 25, 2019 at 4:00 p.m. (Eastern) or as soon thereafter as is practicable.

The Company also requests the Commission confirm the effective date
and time of the Registration Statement in writing.

    APTOSE BIOSCIENCES INC.

    By

    /s/ Gregory K. Chow

    Name:
    Gregory K. Chow

    Title:
    Senior Vice President & Chief

 Financial
Officer

SecProbe.io